HOME >> MEDICINE >> NEWS
Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics

(PHILADELPHIA) -- While new findings from Ohio State University scientists suggest a genetic marker that could help distinguish between chronic pancreatitis and pancreatic cancer and gauge who will do well with cancer treatment, a pharmacologist at the Kimmel Cancer Center at Jefferson in Philadelphia sees the discovery as much more.

The researchers have identified "a new level of biological regulation" and potentially an improved way to profile tumors, says Scott Waldman, M.D., Ph.D., professor and chair of pharmacology and experimental therapeutics at Jefferson Medical College of Thomas Jefferson University in Philadelphia, who co-wrote an editorial about the study appearing May 2, 2007 in the journal JAMA, the Journal of the American Medical Association.

"The findings are significant because they seem to represent a large part of the machinery in the cell that regulates the processing of information from chromosome and gene to the protein machinery that makes the cell run," says Dr. Waldman. "No one knew about this intermediate level of regulation in every cell in the body. Its part of the cells normal machinery that regulates in part how cells become specialized."

The Ohio State team found that preliminary evidence suggesting that the expression pattern of microRNA (miRNAs) small pieces of noncoding genetic material may be useful in distinguishing between chronic pancreatitis and pancreatic cancer and may be able to tell which pancreatic cancer patients will live longer than others. In humans, aberrant expression of miRNAs contributes to cancer by either turning on cancer-causing genes or by inhibiting tumor-blocking genes.

As a result, Dr. Waldman notes, the findings also indicate that these miRNAs can serve as diagnostic markers. "Because they are involved in processes underlying cancer, these specific miRNAs mediate the disease process in different types of cells, such as pancreas or lung, for example," he says. "
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
1-May-2007


Page: 1 2

Related medicine news :

1. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
2. Jefferson immunology researchers show blood-brain barrier damage could affect MS severity
3. Jefferson scientists find that plavix appears to be safe during and after heart bypass
4. Treatment of in-hospital cardiac patients is focus of Jefferson University presentations
5. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes
6. Empathy skills must be given a high priority in medical education, says Jefferson author
7. Natural, soy-based substance might help fight MS, Jefferson neuroscientists find
8. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
9. Obesity tied to higher risk of complications in spinal surgery, Jefferson neurosurgeon finds
10. Jefferson Orthopaedic surgeons leading international study of timing of spinal surgery
11. Jefferson scientists find boosting protein levels staves off heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... 2020 , ... Representatives with Bay-Bay Water today announced that the company has launched ... company logo as part of the ongoing evolution of our company’s brand,” said Osmay Gonzalez, ... company is expanding its national reach. , “We have refreshed our logo to reflect who ...
(Date:2/21/2020)... ... February 21, 2020 , ... Isagenix International , a ... third and final round of Canada finalists for its annual total-body transformation program, ... Markdale, Ontario; Taiya Farrell of Winnipeg, Manitoba; Véronique Collin of Orleans, Ontario; and ...
(Date:2/20/2020)... , ... February 20, 2020 , ... ... has a new release with next generation API integration functionality which enables ... VisitorsCoverage Inc. in 2017, TMQuotes was the first white label software-as-a-service ...
(Date:2/19/2020)... ... February 19, 2020 , ... Actor, director, ... is most known for his acting abilities demonstrated in blockbuster hits like the ... “Behind The Scenes” with Laurence Fishburne. “Behind The Scenes” features a broad array ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... manufacturer, will highlight its growing product portfolio for lower extremities at the American ... Henry B. Gonzalez Convention Center. The Trigon® Ti Stand-Alone Osteotomy Wedge Fixation System ...
Breaking Medicine News(10 mins):
(Date:2/21/2020)... , ... February 21, 2020 , ... Special Learning, Inc. ... The company is passionate about changing the lives of people with autism and ... California focused on helping people find employment opportunities. Special Learning will be providing ...
(Date:2/20/2020)... ... February 20, 2020 , ... Amada Senior Care of ... senior care from trained and knowledgeable Amada caregivers. From day one of opening, ... every client’s unique needs, preferences and desires, all with the goal of delivering ...
(Date:2/20/2020)... ... February 20, 2020 , ... PAINWeekEnd on March 21 ... will be a timely and relevant 2-day program providing busy clinicians and allied ... chronic pain. , In 2020, paper prescriptions for certain painkillers have been banned ...
Breaking Medicine Technology:
Cached News: